Notice of Intent to Sole Source Vitrolife

Closed Special Notice Posted

Solicitation number
HT942525Q0630
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
San Diego, California 92134, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Health Agency (DHA) U.S. Army Medical Research Acquisition Activity (USAMRAA) has issued a Notice of Intent to Sole Source award to Vitrolife, Inc. for specialized fertility testing equipment and supplies. This sole source procurement is being conducted on behalf of the Naval Medical Center San Diego (NMCSD) under FAR 13.106-1(b)(1) authority for purchases not exceeding the simplified acquisition threshold where only one source is reasonably available. The contract will be awarded on a Firm Fixed Price basis for a Viscosity Treatment System, Enhance-S Plus Set, Sperm Wash Medium, and 20 um, 2-chamber MicroCell components. These supplies are required to provide pre-chemotherapy screening and comprehensive infertility investigation services for NMCSD patients. The agency has determined that Vitrolife, Inc. is the only vendor capable of meeting NMCSD's current operational needs while maintaining continuity of testing procedures.

The primary objective of this sole source procurement is to ensure uninterrupted fertility testing services at NMCSD without requiring extensive revalidation procedures that would accompany switching to alternative suppliers. Any interested firms must submit written responses identifying their interest and capability to provide these services by 2:00 PM Eastern Standard Time on July 15, 2025, to the contracting point of contact James Cheng at james.cheng1.civ@health.mil. The government justifies the sole source approach by explaining that Vitrolife's current system components are already FDA approved, assessed, validated, and approved for use, while introducing alternative reagents would require reassessment and revalidation under Clinical and Laboratory Standards Institute (CLSI) and College of American Pathologist (CAP) accreditation requirements. Contractors interested in challenging this sole source determination must demonstrate their capability to provide equivalent services without disrupting current operations. The notice explicitly states that telephone requests will not be honored and that the final determination whether to compete this contract remains at the government's discretion.

Notice text

The Defense Health Agency (DHA) U.S. Army Medical Research Acquisition Activity (USAMRAA) intends to award a Firm Fixed Price sole source contract on behalf of the Naval Medical Center San Diego (NMSCD) to Vitrolife, Inc., under the authority FAR 13.106-1(b)(1): For purchases not exceeding the simplified acquisition threshold (SAT), only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name, or industrial mobilization).

This requirement is for a Viscosity Treatment System, Enhance-S Plus Set, Sperm Wash Medium and the 20 um, 2-chamber MicroCell for fertility testing. These reagents and supplies required provide pre-chemotherapy screening and comprehensive infertility investigation for NMCSD patients.

Vitrolife, Inc. is the only vendor able to provide the reagents and supplies that can meet the current needs of NMCSD. Use of Vitrolife Inc. reagents and supplies will ensure the continuity of testing for the investigation of current conditions and or functions of existing systems. Any change to the product necessitates thorough investigation, assessment and approval of individual components utilized in the testing procedure in accordance with the Clinical and Laboratory Standards Institute (CLSI) and College of American Pathologist (CAP) accreditation requirements. Current Vitrolife system components in use are FDA approved, have been assessed, validated and approved for use, hence ready for use and require no further assessment for continued use beyond applicable accreditation requirements. Other reagents are available, however the methodology, kit/reagent complexity and/or protocols will require reassessment and revalidation if introduced. Modification of procedures will result in delays and/or necessity to refer patients to outside networks for service.

This is a notice of intent to issue a contract on a Sole Source basis. This notice of intent is NOT a request for quotations (RFQ). Any other firms desiring consideration must fully identify their interest and capability to provide these services to the individual listed below. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Interested persons may identify their interest in writing, to the Government point of contact. Responses to this notice must be received no later than 2:00 PM Eastern Standard Time, 15 July 2025. The point of contact for this action is James Cheng, james.cheng1.civ@health.mil. No telephone requests will be honored.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Intent to Sole Source - Fertility Preservation Lab Services Bethesda, Maryland 20892, United States · NAICS 621410 National Institutes of Health No set-aside
Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. Medical Command No set-aside
J066--Azenta NitroStore System PM and Support Services NAICS 811210 Veterans Integrated Service Network 4 No set-aside
6515 - Intent to Sole Source - Siemens Skyra Coldhead RDE-412L4 (11472997 San Francisco, California 94121, United States · NAICS 339112 Veterans Integrated Service Network 21 No set-aside
Notice of Intent to Sole Source ONKOS Surgical MY3D Distal Radial Osteotomy Kit for Naval Medical Center Portsmouth Portsmouth, Virginia 23708, United States · NAICS 339113 Defense Health Agency No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity